Thyroid Cancer Treatment: Radioiodine Strategies

We are comparing two treatment strategies for intermediate-risk differentiated thyroid cancer patients to see which is more effective. This study will also evaluate patient quality of life and side effects over time.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Theracap 131
Theracap131 Pour Thérapie

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

131i-Meta-Iodobenzyl-Guanidine Sulfate
131I-meta-iodobenzyl-guanidine sulfate is a radioactive compound used to detect and treat certain neuroendocrine tumors by delivering targeted radiation to tumor cells.
Sodium Iodide (131i)
Sodium iodide (I-131) is a radioactive substance used to destroy overactive thyroid tissue and treat thyroid cancer.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

[|1231] Sodium Iodide Ge Healthcare
[|1231] Sodium Iodide Ge Healthcare
[123i] Sodium Iodide Ge Healthcare

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
CHU De Martinique
médecine nucléaire
Amilly, France
Centre Hospitalier Universitaire D'Angers
médecine nucléaire
Angers, France
Institut De Cancerologie De L Ouest
médecine nucléaire
Angers, France

Sponsor: Centre Francois Baclesse
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.